Horizon Europe: New calls for the September 2023 deadline

21/05/23 17:06

The current funding opportunities in the Horizon Europe Programme Cluster Health are listed below.
Further open funding opportunities can be found here.

      Call-ID     Deadline     Topic     Funding per project 
[in Mio €]     Funding rate     Call-budget 
[in Mio €]     Process 
[stages]   
      Destination 1. Staying healthy in a rapidly changing society   
      1.2 Staying Healthy (Two stage - 2024): HORIZON-HLTH-2023-STAYHLTH-01-two-stage   
      STAYHLTH-01-02     19.09.23     Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society     8-10     RIA (Blind evaluation pilot, Lump sum)     30     2   
      STAYHLTH-01-05     19.09.23     Personalised prevention of non-communicable diseases - addressing areas of unmet needs using multiple data sources     8-12     RIA (Blind evaluation pilot, Lump sum)     50     2   
      Destination 2. Living and working in a health-promoting environment   
      2.2 Environment and health (Two stage - 2024): HORIZON-HLTH-2024-ENVHLTH-02   
      ENVHLTH-02-06     19.09.23     The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution     7-8     RIA (blind evaluation pilot, lump sum)     60     2   
      Destination 3. Tackling diseases and reducing disease burden   
      3.2 Partnerships in Health (2023): HORIZON-HLTH-2023-DISEASE-07   
      DISEASE-07-01     19.09.23     European Partnership on Rare Diseases     around 50     RIA     50     1   
      3.3 Tackling diseases (Two stage - 2024): HORIZON-HLTH-2024-DISEASE-03   
      DISEASE-03-08     19.09.23     Comparative effectiveness research for healthcare interventions in areas of high public health need     6-7     RIA (blind evaluation pilot, lump sum)     45     2   
      DISEASE-03-11     19.09.23     Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness     8-10     RIA (blind evaluation pilot, lump sum)     30     2   
      DISEASE-03-13     19.09.23     Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders     6-8     RIA (blind evaluation pilot, lump sum)     25     2   
      DISEASE-03-14     19.09.23     Tackling high-burden for patients, under-researched medical conditions     6-7     RIA (blind evaluation pilot, lump sum)     25     2   
      3.4 Tackling diseases (Single stage - 2024): HORIZON-HLTH-2024-DISEASE-08   
      DISEASE-08-12     11.04.24     Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness     around 2     CSA     2     1   
      DISEASE-08-20     11.04.24     Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential     7-8     RIA     50     1   
      3.5 Partnerships in Health (2024): HORIZON-HLTH-2024-DISEASE-09   
      DISEASE-09-01     11.04.24     European Partnership: One Health Anti-Microbial Resistance     around 100     COFUND     100     1   
      Destination 4. Ensuring access to innovative, sustainable and high-quality health care   
      4.2 Ensuring access to innovative, sustainable and high-quality health care (Two stage - 2024): HORIZON-HLTH-2024-CARE-04   
      CARE-04-04     19.09.23     Access to health and care services for people in vulnerable situations     4-6     RIA (blind evaluation pilot, lump sum)     30     2   
      Destination 5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society   
      5.2 Tools and technologies for a healthy society (Two stage - 2024): HORIZON-HLTH-2024-TOOL-05   
      TOOL-05-06     19.09.23     Innovative non-animal human-based tools and strategies for biomedical research     4-8     RIA (blind evaluation pilot, lump sum)     25     2   
      5.3 Tools and technologies for a healthy society (Single stage - 2024): HORIZON-HLTH-2024-TOOL-11   
      TOOL-11-02     11.04.24     Bio-printing of living cells for regenerative medicine     6-8     RIA     25     1   
      Destination 6. Maintaining an innovative, sustainable and globally competitive health industry   
      6.2 A competitive health-related industry (Single stage - 2024): HORIZON-HLTH-2024-IND-06   
      IND-06-08     11.04.24     Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs)     8-10     RIA     10     1   
      IND-06-09     11.04.24     Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators     around 2     CSA     2     1

Call-ID	Deadline	Topic	Funding per project [in Mio €]	Funding rate	Call-budget [in Mio €]	Process [stages]
Destination 1. Staying healthy in a rapidly changing society
1.2 Staying Healthy (Two stage - 2024): HORIZON-HLTH-2023-STAYHLTH-01-two-stage
STAYHLTH-01-02	19.09.23	Towards a holistic support to children and adolescents’ health and care provisions in an increasingly digital society	8-10	RIA (Blind evaluation pilot, Lump sum)	30	2
STAYHLTH-01-05	19.09.23	Personalised prevention of non-communicable diseases - addressing areas of unmet needs using multiple data sources	8-12	RIA (Blind evaluation pilot, Lump sum)	50	2
Destination 2. Living and working in a health-promoting environment
2.2 Environment and health (Two stage - 2024): HORIZON-HLTH-2024-ENVHLTH-02
ENVHLTH-02-06	19.09.23	The role of environmental pollution in non-communicable diseases: air, noise and light and hazardous waste pollution	7-8	RIA (blind evaluation pilot, lump sum)	60	2
Destination 3. Tackling diseases and reducing disease burden
3.2 Partnerships in Health (2023): HORIZON-HLTH-2023-DISEASE-07
DISEASE-07-01	19.09.23	European Partnership on Rare Diseases	around 50	RIA	50	1
3.3 Tackling diseases (Two stage - 2024): HORIZON-HLTH-2024-DISEASE-03
DISEASE-03-08	19.09.23	Comparative effectiveness research for healthcare interventions in areas of high public health need	6-7	RIA (blind evaluation pilot, lump sum)	45	2
DISEASE-03-11	19.09.23	Pandemic preparedness and response: Adaptive platform trials for pandemic preparedness	8-10	RIA (blind evaluation pilot, lump sum)	30	2
DISEASE-03-13	19.09.23	Validation of fluid-derived biomarkers for the prediction and prevention of brain disorders	6-8	RIA (blind evaluation pilot, lump sum)	25	2
DISEASE-03-14	19.09.23	Tackling high-burden for patients, under-researched medical conditions	6-7	RIA (blind evaluation pilot, lump sum)	25	2
3.4 Tackling diseases (Single stage - 2024): HORIZON-HLTH-2024-DISEASE-08
DISEASE-08-12	11.04.24	Pandemic preparedness and response: Maintaining the European partnership for pandemic preparedness	around 2	CSA	2	1
DISEASE-08-20	11.04.24	Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential	7-8	RIA	50	1
3.5 Partnerships in Health (2024): HORIZON-HLTH-2024-DISEASE-09
DISEASE-09-01	11.04.24	European Partnership: One Health Anti-Microbial Resistance	around 100	COFUND	100	1
Destination 4. Ensuring access to innovative, sustainable and high-quality health care
4.2 Ensuring access to innovative, sustainable and high-quality health care (Two stage - 2024): HORIZON-HLTH-2024-CARE-04
CARE-04-04	19.09.23	Access to health and care services for people in vulnerable situations	4-6	RIA (blind evaluation pilot, lump sum)	30	2
Destination 5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society
5.2 Tools and technologies for a healthy society (Two stage - 2024): HORIZON-HLTH-2024-TOOL-05
TOOL-05-06	19.09.23	Innovative non-animal human-based tools and strategies for biomedical research	4-8	RIA (blind evaluation pilot, lump sum)	25	2
5.3 Tools and technologies for a healthy society (Single stage - 2024): HORIZON-HLTH-2024-TOOL-11
TOOL-11-02	11.04.24	Bio-printing of living cells for regenerative medicine	6-8	RIA	25	1
Destination 6. Maintaining an innovative, sustainable and globally competitive health industry
6.2 A competitive health-related industry (Single stage - 2024): HORIZON-HLTH-2024-IND-06
IND-06-08	11.04.24	Developing EU methodological frameworks for clinical/performance evaluation and post-market clinical/performance follow-up of medical devices and in vitro diagnostic medical devices (IVDs)	8-10	RIA	10	1
IND-06-09	11.04.24	Gaining experience and confidence in New Approach Methodologies (NAM) for regulatory safety and efficacy testing – coordinated training and experience exchange for regulators	around 2	CSA	2	1

2024
2023
2022
2021
2020
2019
2018
2017